Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Biol Reprod ; 73(4): 825-32, 2005 Oct.
Article in English | MEDLINE | ID: mdl-15972887

ABSTRACT

In this study, we test the hypothesis that the growth-promoting action of androgens on granulosa cells requires paracrine signaling from the oocyte. Mural granulosa cells (MGCs) from small antral (1-3 mm) prepubertal pig follicles were cultured in the presence or absence of denuded oocytes (DO) from the same follicles to determine whether mitogenic and/or steroidogenic responses, to combinations of FSH, insulin-like growth factor 1 (IGF1), and dihydrotestosterone (DHT) were influenced by oocyte-secreted factors (OSFs). To further explore the identity of such factors we performed the same experiments, substituting growth differentiation factor 9 (GDF9), a known OSF, for the DO. OSFs and GDF9 both potently enhanced IGF1-stimulated proliferation, and inhibited FSH-stimulated progesterone secretion. Alone, DHT had little effect on DNA synthesis, but significantly enhanced the mitogenic effects of OSFs or GDF9 in the presence of IGF1. Denuded oocytes, GDF9, and DHT independently inhibited FSH-stimulated progesterone secretion, and androgen, together with DO or GDF9, caused the most potent steroidogenic inhibition. Focusing on mitogenic effects, we demonstrate that both natural androgen receptor (AR) agonists, testosterone and DHT, dose-dependently augmented the mitogenic activity of DO or GDF9. Antiandrogen (hydroxyflutamide) treatment, which is used to block androgen receptor activity, opposed the interaction between androgen and GDF9. In conclusion, androgens stimulate porcine MGC proliferation in vitro by potentiating the growth-promoting effects of oocytes or GDF9, via a mechanism that involves the AR. These signaling pathways are likely to be important regulators of folliculogenesis in vivo, and may contribute to the excess follicle growth that is observed in androgen-treated female animals.


Subject(s)
Androgens/pharmacology , Granulosa Cells/drug effects , Intercellular Signaling Peptides and Proteins/pharmacology , Oocytes/metabolism , Androgen Antagonists/pharmacology , Animals , Bone Morphogenetic Protein 15 , Cell Proliferation , Cells, Cultured , Coculture Techniques , Dihydrotestosterone/pharmacology , Dose-Response Relationship, Drug , Female , Flutamide/analogs & derivatives , Flutamide/pharmacology , Follicle Stimulating Hormone/pharmacology , Granulosa Cells/physiology , Growth Differentiation Factor 9 , Insulin-Like Growth Factor I/pharmacology , Intercellular Signaling Peptides and Proteins/genetics , Mice , Mitogens/pharmacology , Progesterone/metabolism , Recombinant Proteins/genetics , Recombinant Proteins/isolation & purification , Recombinant Proteins/pharmacology , Swine , Testosterone/pharmacology
2.
Biol Reprod ; 71(1): 45-52, 2004 Jul.
Article in English | MEDLINE | ID: mdl-14973257

ABSTRACT

Androgens acting via the androgen receptor (AR) have been implicated in regulation of folliculogenesis in many animal species. These effects are possibly mediated via enhancement of FSH and/or insulin-like growth factor (IGF)-I activity in granulosa cells, which contain high levels of AR protein. We examined the in vitro effect of dihydrotestosterone (DHT) on DNA synthesis and progesterone secretion by follicular cells in response to FSH and IGF-I, alone or in combination. Cells from separate pools of 1- to 3-mm and 3- to 5-mm antral follicles were aspirated from gilt ovaries and fractioned into mural granulosa cells (MGCs) and cumulus-oocyte complexes (COCs) for subsequent cell culture. Androgen alone or with any combination of mitogen had minimal effect on proliferative and no effect on steroidogenic responses of MGCs from 3- to 5-mm antral follicles. Conversely, in MGCs from 1- to 3-mm follicles, DHT significantly enhanced IFG-I-stimulated proliferation and had variable influence on progesterone secretion. The effects of DHT on proliferative responses of COCs were also dependent on follicle size: DHT significantly augmented either IGF-I-stimulated proliferation (1- to 3-mm follicles) or FSH-stimulated proliferation (3- to 5-mm follicles). However, the steroidogenic responses of all COCs were identical, whereby DHT significantly suppressed progesterone secretion, predominantly in the presence of FSH. Addition of an AR antagonist, hydroxyflutamide, generally reversed the proliferative responses invoked by DHT but not the steroidogenic responses. We conclude that androgen-receptor-mediated activity in granulosa cells of antral follicles is dependent on follicle size, is influenced by proximity of cells to the oocyte, and possibly involves both classic and nonclassic steroid mechanisms.


Subject(s)
Androgens/physiology , Flutamide/analogs & derivatives , Granulosa Cells/cytology , Granulosa Cells/metabolism , Growth Substances/physiology , Progesterone/metabolism , Androgen Antagonists/pharmacology , Animals , Cell Division/drug effects , Cell Division/physiology , DNA/biosynthesis , Dihydrotestosterone/pharmacology , Drug Combinations , Female , Flutamide/pharmacology , Follicle Stimulating Hormone/pharmacology , Insulin-Like Growth Factor I/pharmacology , Swine , Time Factors
SELECTION OF CITATIONS
SEARCH DETAIL
...